Abacavir Sulfate CAS Number 188062-50-2

Abacavir sulfate, chemically defined as CAS number 188062-50-2, acts as a highly effective HIV medication. It inhibits the multiplication of the human immunodeficiency virus (HIV) by stopping the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, allowing the virus to integrate its genetic material into the host's DNA

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate serves as a nucleoside reverse transcriptase inhibitor administered in the treatment of human immunodeficiency virus syndrome. Its mechanistic properties rely on the competitive inhibition of reverse transcriptase, an enzyme vital for HIV replication. Abacavir sulfate is a derivative that transits transformation to its active form

read more

Leading API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for organizations of all sizes. The premier global API manufacturer and supplier delivers a comprehensive selection of cutting-edge APIs designed to meet the diverse needs of modern applications. With a proven commitment to quality, innovation, and

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate acts as a nucleoside reverse transcriptase inhibitor administered in the treatment of human immunodeficiency virus disease. Its therapeutic properties involve the competitive inhibition of reverse transcriptase, an enzyme essential for HIV replication. Abacavir sulfate is a derivative that experiences modification to its active fo

read more

India's Premier Nutraceutical API Producer

India has firmly established itself as a global hub for dietary supplement ingredient creation, particularly in the realm of Active Pharmaceutical Ingredients (compounds). Numerous Indian firms specialize in the contract manufacture of natural health APIs, serving both the national market and exporting globally. These businesses boast advanced faci

read more